Mary Ann Liebert, Inc., publishers has announced that Dr. Daniele Piomelli has been appointed Editor-in-Chief of Cannabis and Cannabinoid Research. Dr. Piomelli serves as Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine. He is also founding director of the unit of drug discovery and development (D3) at the Italian Institute of Technology in Genoa, Italy.
Dr. Piomelli is the author of more than 300 peer-reviewed articles, three full-length books, and 25 patents. He has received several awards and honours, including the Dargut and Milena Kemali Prize in Neuroscience and the National Alliance for Research on Depression and Schizophrenia (NARSAD) Outstanding Investigator Award.
He has made several contributions to the pharmacology of lipid-based signalling molecules. With his collaborators, he elucidated the biochemical pathways involved in the formation and deactivation of endocannabinoid substances – including anandamide and 2-AG – and uncovered various physiological functions served by these substances in the brain and in peripheral tissues. Additionally, his lab discovered the role of the lipid amides – oleoylethanolamide and palmitoylethanolamide – in the control of energy balance, inflammation, and pain, and identified their cellular receptors.
Cannabis and Cannabinoid Research claims to be the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoids system. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioural, social, and epidemiological issues; and ethical, legal, and regulatory controversies.
Dr. Piomelli will take editorship immediately and begin developing the Journal to launch in Fall of 2015.
